Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 4
2011 4
2012 1
2013 3
2014 3
2015 10
2016 5
2017 4
2018 3
2019 1
2020 3
2021 2
2022 3
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean dash cherepanov (25 results)?
Global epidemiology of amyloid light-chain amyloidosis.
Kumar N, Zhang NJ, Cherepanov D, Romanus D, Hughes M, Faller DV. Kumar N, et al. Among authors: cherepanov d. Orphanet J Rare Dis. 2022 Jul 19;17(1):278. doi: 10.1186/s13023-022-02414-6. Orphanet J Rare Dis. 2022. PMID: 35854312 Free PMC article.
Comparison of health care costs and resource utilization for commonly used proteasome inhibitor-immunomodulatory drug-based triplet regimens for the management of patients with relapsed/refractory multiple myeloma in the United States.
Sanchez L, Chari A, Cheng M, Cherepanov D, DerSarkissian M, Huang F, Stull DM, Dabora J, Young M, Noga SJ, Pi S, Zhang M, Banatwala A, Duh MS, Ailawadhi S. Sanchez L, et al. Among authors: cherepanov d. J Manag Care Spec Pharm. 2023 Nov;29(11):1205-1218. doi: 10.18553/jmcp.2023.23031. Epub 2023 Sep 30. J Manag Care Spec Pharm. 2023. PMID: 37776124 Free PMC article.
Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study.
Bringhen S, Pour L, Benjamin R, Grosicki S, Min CK, C de Farias DL, Vorog A, Labotka RJ, Wang B, Cherepanov D, Cain LE, Manne S, Rajkumar SV, Dimopoulos MA. Bringhen S, et al. Among authors: cherepanov d. Clin Lymphoma Myeloma Leuk. 2023 Jul;23(7):491-504. doi: 10.1016/j.clml.2023.03.007. Epub 2023 Mar 29. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37149398 Free article. Clinical Trial.
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors.
Strosberg JR, Fisher GA, Benson AB, Anthony LB, Arslan B, Gibbs JF, Greeno E, Iyer RV, Kim MK, Maples WJ, Philip PA, Wolin EM, Cherepanov D, Broder MS. Strosberg JR, et al. Among authors: cherepanov d. World J Gastroenterol. 2015 Feb 28;21(8):2450-9. doi: 10.3748/wjg.v21.i8.2450. World J Gastroenterol. 2015. PMID: 25741154 Free PMC article. Review.
IDENTIFICATION OF POTENTIAL MARKERS FOR CUSHING DISEASE.
Broder MS, Chang E, Cherepanov D, Neary MP, Ludlam WH. Broder MS, et al. Among authors: cherepanov d. Endocr Pract. 2016 May;22(5):567-74. doi: 10.4158/EP15914.OR. Epub 2016 Jan 20. Endocr Pract. 2016. PMID: 26789346
52 results